Around 5 % of the population suffers from excessive daytime sleepiness and/or hypersomnolence. For those affected it can lead to an irrepressible need to sleep or even to unavoidable ‘sleep attacks’ with undesired sleeping episodes (microsleep). The SPHYNCS study takes a closer look at these disorders. With this in mind, blood samples and samples of cerebrospinal fluid are taken from test subjects at several sleep centres, which must then be transported as quickly as possible to the Inselspital in Bern and to the ETH Zurich. In the following testimonial report you will learn how quickly and sustainably swissconnect transports these samples to their destination and how simple the digital ordering process is.
Clinical study SPHYNCS
The Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) involves clinical research into sleep disorders and is being conducted under the supervision of the Inselspital Bern. Seven Swiss sleep centres (Barmelweid, Basel, Bern, Lugano, St. Gallen, Zurich and Zurzach) are participating in the study. At the sleep centres blood and if necessary cerebrospinal fluid are collected from the test subjects. The blood sample must be sent as quickly as possible to the Department of Neurology at the Inselspital Bern and the spinal fluid to the Institute for Microbiology at the ETH Zurich. There, the samples are exhaustively analysed with the aim of finding new diagnostic markers enabling improvements in the classification of sleep disorders.
The straightforward ordering process and the quick and eco-friendly transportation of the samples make swissconnect the perfect logistics partner for our clinical studies concerning research into sleep disorders.
Project Coordinator SPHYNCS Study, Inselspital Bern.
Are you looking for an express logistics partner?
Whether on the telephone, via e-mail or a visit in person – we’re here for you.